Enzyme-inducing effects of bicalutamide in mouse, rat and dog

References

• BOYLE, G. W., MCKILLOP, D., PHILLIPS, P. J., HARDING, J. R., PICKFORD, R. and McCoamicx, A. D. 1993, Metabolism of Casodex in laboratory animals. Xenobiotica, 23, 781–798.
   PubMed Web of Science ®Google Scholar
• BRECKENRIDGE, A., 1987, Enzyme induction in man. Clinical aspects—an overview. In Enzyme Induction in Man, edited by E. A. Sotaniemi and R. 0. Pelkonen (London: Taylor & Francis), pp. 201–209.
   Google Scholar
• COCKSHOTT, I. D., COOPER, K. J., SWEETMORE, D. S., BLACKLOCK, N. J. and DENIS, L., 1990, The pharmacokinetics of Casodex in prostate cancer patients after single and multiple dosing. European Urology, 18 (suppl. 3), 10–17.
   PubMed Web of Science ®Google Scholar
• COCKSHOTT, I. D., PLUMMER, G. F., COOPER, K. J. and WARWICK, M. J., 1991, The pharmacokinetics of Casodex in laboratory animals. Xenobiotica, 21, 1347–1355.
   PubMed Web of Science ®Google Scholar
• CORCOS, L., 1992, Phenobarbital and dexamethasone induce expression of cytochrome P450 genes from subfamilies IIB, IIC and IIIA in mouse liver. Drug Metabolism and Disposition, 20, 797–801.
   PubMed Web of Science ®Google Scholar
• DIAMOND, S., RAKESTRAW, D., O'NEIL, J., LAM, G. N. and CHRIST, D. D., 1994, Induction of cytochromes P450 2B and 3A in mice following the dietary administration of the novel cognitive enhancer linopirdine. Drug Metabolism and Disposition, 22, 65–73.
   Google Scholar
• FORKERT, P. G., MIREHOUSE -BROWN, P., PARK, S. S. and GELBOIN, H. H., 1988, Distribution and induction sites of phenobarbital- and 3-methylcholanthrene-inducible cytochromes P450 in murine liver: immunohistochemical localisation with monoclonal antibodies. Molecular Phar-macology, 34, 736–743.
   Google Scholar
• FURR, B. J. A., 1989, Casodex (ICI 176,334)—a new, pure, peripherally selective antiandrogen: preclinical studies. Hormone Research, 32 (Suppl 1), 69–76.
   PubMedGoogle Scholar
• FURR, B. J. A., BLACKLEDGE, G. and COCKSHOTT, I. D., 1996, Casodex, preclinical and clinical studies. In Hormone-Dependent Cancer, edited by J. R. Pasqualini and B. S. Katzenellenbogen (New York: Marcel Dekker), pp. 397–424.
   Google Scholar
• HOSTELTER, K. A., WRIGHTON, S. A., MOLOWA, D. T., THOMAS, P. E., LEVIN, W. and GUZELIAN, P. S., 1989, Coinduction of multiple hepatic cytochrome P450 proteins and their mRNAs in rats treated with imidazole antimycotic agents. Molecular Pharmacology, 35, 279–285.
   PubMedGoogle Scholar
• ISWARAN, T. J., IrviAI, M., BETTON, G. R. and SIDDAL, R. A., 1977, An overview of animal toxicology studies with bicalutamide (ICI 176,334). journal of Toxicological Sciences, 22, 75–88.
   Google Scholar
• KAISARY, A., KLARSKOV, P. and McKILL0E, D., 1996, Absence of enzyme induction in prostate cancer patients receiving Casodex (bicalutamide). Anti-Cancer Drugs, 7, 54–59.
   Google Scholar
• LAEMMLI U. K., 1970, Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature, 227, 680–685.
   PubMed Web of Science ®Google Scholar
• LUMLEY, J. S. P., GREEN, C. J., LEAR, P. and ANGELL -JAMES, J. E., 1990, Essentials of Experimental Surgery (London: Butterworths).
   Google Scholar
• MCCLAIN, R. M., 1989, The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: Implications for thyroid gland neoplasia. Toxicologic Pathology, 17, 294–306.
   PubMed Web of Science ®Google Scholar
• McKILLOP, D., 1985, Effects of phenobarbitone and /3-naphthoflavone on hepatic microsomal drug metabolising enzymes of the male beagle dog. Biochemical Pharmacology, 34, 3137–3142.
   PubMedGoogle Scholar
• McKILLOP, D., BOYLE, G. W., COCKSHOTT, I. D., JONES, D. C., PHILLIPS, P. J. and YATES, R. A., 1993, Metabolism and enantioselective pharmacokinetics of Casodex in man. Xenobiotica, 23, 1241–1253.
   PubMed Web of Science ®Google Scholar
• MCKILLOP, D., SIMONS, P. J., COCKSHOTT, I. D., HILL, S. J., HARDING, J. R., COOPER, K. J. and Jos, D. C., 1995, Enantioselective metabolism and pharmacokinetics of Casodex in the male rat. Xenobiotica, 25, 623–634.
   PubMed Web of Science ®Google Scholar
• NEWMAN, S. L. and GUZELIAN, P. S., 1983, Identification of the cyanopregnenolone-inducible form of hepatic cytochrome P450 as a catalyst of aldrin epoxidation. Biochemical Pharmacology, 32, 1529–1531.
   PubMed Web of Science ®Google Scholar
• PARKINSON, A., CLEMENT, R. P., CASCLkNO, C. N. and CAYEN, M. N., 1992, Evaluation of loratidine as an inducer of liver microsomal cytochrome P450 in rats and mice. Biochemical Pharmacology, 43, 2169–2180.
   PubMed Web of Science ®Google Scholar
• PRUEKSARITANONT, T., CORREIA, M. A., RETTlE, A. E., SWINNEY, D. C., THOMAS, P. E. and BENET, L. Z., 1993, Cyclosporine metabolism by rat liver microsomes. Evidence for involvement of enzyme(s) other than cytochromes P450 3A. Drug Metabolism and Disposition, 21, 730–737.
   PubMed Web of Science ®Google Scholar
• RITTER, J. K. and FRANKLIN, M. R., 1987, High magnitude hepatic cytochrome P450 induction by an N-substituted imidazole antimycotic, clotrimazole. Biochemical Pharmacology, 36, 2783–2787.
   PubMed Web of Science ®Google Scholar
• RUSH, W. R., SMITH, S. A., MULVEY, J. H., GRAHAM, D. J. M. and CHAPLIN, M. D., 1987, Inhibition and induction of hepatic drug metabolism in rats and mice by nafimidone and its major metabolite nafimidone alcohol. Drug Metabolism and Disposition, 15,571–578.
   Google Scholar
• STERNBERGER, L. A., HARDY, P. N. H., CUCULIS, J. J. and MEYER, H. G., 1970, The unlabelled antibody—enzyme method of immunohistochemistry : preparation and properties of soluble antigen—antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in the identification of spirochetes. Histochemical Cytochemistry, 18,315–333.
   Google Scholar
• TOMLINSON, P. W., JEFFERY, D. J. and FILER, C. W., 1981, A novel technique for assessment of biliary secretion and enterohepatic circulation in the unrestrained conscious rat. Xenobiotica, 12, 863–870.
   Web of Science ®Google Scholar
• TREIMAN, D. M., WILENSKY, A. J., BEN -MENACHEM, E., OJEMANN, L., YERBY, M., BARBER, K. O'L., McCoRmicx, K. B., CEREGHINO, J. J., WHITE, B. G. and SWISHER, K., 1985, Efficacy of nafimidone in the treatment of intractable partial seizures: report of a two-center pilot study. Epilepsia, 26,607–611.
   Google Scholar
• WOLFF, T. and GUENGERICH, F. P., 1987, Rat liver cytochrome P450 isozymes as catalysts of aldrin epoxidation in reconstituted monooxygenase systems and microsomes. Biochemical Pharmacology, 36, 2581–2588.
   PubMed Web of Science ®Google Scholar
• WRIGHTON, S. A., SCHUETZ, E. G., WATKINS, P. B., MAUREL, P., BARWICK, J., BAILEY, B. S., HARTLE, H. T., YOUNG, B. and GUZELIAN, P., 1985, Demonstration in multiple species of inducible hepatic cytochromes P450 and their mRNAs related to the glucocorticoid-inducible cytochrome P450 of the rat. Molecular Pharmacology, 28,312–321.
   PubMed Web of Science ®Google Scholar